Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline

BACKGROUND: Gastric cancer is one of the most common malignancies worldwide. Epirubicin (EPI) is used extensively in the treatment of multiple cancers despite its tendency to induce multidrug resistance though overexpression of the ABCB1 efflux pump. However, this overexpression can be disrupted usi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Asian Pac J Cancer Prev
Päätekijät: Felipe, Aledson Vitor, de Oliveira, Juliana, Moraes, Andrea Aparecida, de França, Jerônimo Pereira, da Silva, Tiago Donizetti, Forones, Nora Manoukian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: West Asia Organization for Cancer Prevention 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031827/
https://ncbi.nlm.nih.gov/pubmed/29801407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.5.1237
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia